Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety, Immunogenicity Study of GSK Biologicals' Pandemic Influenza Candidate Vaccine (H1N1) (GSK2340272A)
This study has been completed.
Study NCT00971321   Information provided by GlaxoSmithKline

First Received on August 27, 2009.   Last Updated on June 30, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Sponsors listed in this trial